1. Home
  2. QTTB vs INCR Comparison

QTTB vs INCR Comparison

Compare QTTB & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Q32 Bio Inc.

QTTB

Q32 Bio Inc.

HOLD

Current Price

$4.69

Market Cap

44.3M

Sector

Health Care

ML Signal

HOLD

Logo Intercure Ltd.

INCR

Intercure Ltd.

HOLD

Current Price

$0.90

Market Cap

50.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QTTB
INCR
Founded
2015
1994
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
44.3M
50.4M
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
QTTB
INCR
Price
$4.69
$0.90
Analyst Decision
Hold
Analyst Count
1
0
Target Price
$15.00
N/A
AVG Volume (30 Days)
156.4K
48.9K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$69.54
Revenue Next Year
N/A
$41.75
P/E Ratio
N/A
N/A
Revenue Growth
100.00
N/A
52 Week Low
$1.38
$0.68
52 Week High
$6.37
$1.77

Technical Indicators

Market Signals
Indicator
QTTB
INCR
Relative Strength Index (RSI) 57.02 34.38
Support Level $3.99 $0.76
Resistance Level $4.36 $0.90
Average True Range (ATR) 0.40 0.06
MACD -0.00 0.00
Stochastic Oscillator 62.50 36.01

Price Performance

Historical Comparison
QTTB
INCR

About QTTB Q32 Bio Inc.

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function.

About INCR Intercure Ltd.

Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.

Share on Social Networks: